What is CPRX's health score?

CATALYST PHARMACEUTICALS, INC. (CPRX) has a TradeApes health score of 74 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CPRX's estimated fair value?

Based on our 5-year discounted cash flow model, CATALYST PHARMACEUTICALS, INC.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is CPRX undervalued or overvalued?

Our model currently rates CPRX as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for CPRX... Refresh in a moment for the full analysis.

CATALYST PHARMACEUTICALS, INC. (CPRX)

Healthcare Undervalued low healthy

$31.29

Updated: 2026-06-05

TradeApes Score

Financial Strength

90 Strong

Operating Trend

68 Healthy

Relative Value

75 Strong

Capital Allocation

50 Mixed

Risk

80 Strong

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.